Variant Phenotype Annotation
证据URL
https://www.pharmgkb.org/variantAnnotation/1184348998
总结
CYP2C19 *1/*2 + *2/*17 (assigned as intermediate metabolizers phenotype) is associated with decreased mean peak plasma concentration of H4 when treated with clopidogrel in people with Cardiovascular Diseases as compared to CYP2C19 *1/*1.